AI in Precision Medicine Market Expands with Genomics and Personalized Therapy Innovations

Global AI in Precision Medicine Market reached US$ 1,703.19 Million in 2024 and is expected to reach US$ 32,410 Million by 2033, growing at a CAGR of 38.7 % during the forecast period of 2025-2033.

The AI in Precision Medicine Market refers to the sector focused on integrating artificial intelligence (AI) technologies with precision medicine to provide tailored diagnosis, treatment, and patient care. AI algorithms analyze complex clinical, genomic, and lifestyle data to identify disease patterns, predict outcomes, and recommend personalized therapeutic strategies. This market includes AI-powered tools for drug discovery, genomics analysis, predictive diagnostics, treatment planning, and real-time monitoring, serving hospitals, research institutions, and pharmaceutical companies.

📌 Access valuable insights with our sample report - (Please enter your Corporate Email ID to get priority access):- https://datamintelligence.com/download-sample/ai-in-precision-medicine-market?rk

☛ AI in Precision Medicine Market Forces Driving Future Growth

The AI in precision medicine market is being driven by the rising prevalence of chronic and rare diseases, increasing adoption of genomics-based diagnostics, and growing investments in AI technologies for healthcare. AI accelerates drug discovery, identifies patient subgroups for targeted therapies, and improves clinical decision-making, thereby enhancing treatment efficacy and patient outcomes. Integration with electronic health records (EHRs) and wearable devices further strengthens personalized care delivery.

However, challenges such as data privacy concerns, regulatory complexities, and high implementation costs can limit adoption. Limited interoperability of healthcare systems and the need for large, high-quality datasets for AI model training are also key hurdles.

Opportunities in the market include expansion of AI-driven tools for oncology, rare disease management, and chronic condition monitoring, as well as partnerships between AI technology providers and pharmaceutical firms for drug development. Additionally, cloud computing and advanced analytics platforms enable broader adoption of AI-powered precision medicine solutions globally.

☛ AI in Precision Medicine Industry News:

Collaborations: AI startups partnered with leading pharma companies to accelerate precision drug development and patient stratification.

Clinical Integration: Hospitals in North America and Europe are implementing AI-based predictive analytics for oncology and cardiovascular treatments.

Regulatory Advances: Emerging frameworks for AI in healthcare are supporting faster adoption of AI-based diagnostic and treatment tools.

Funding & Investments: Venture capital funding in AI-driven precision medicine solutions has surged, particularly for genomics and rare disease applications.

☛ AI in Precision Medicine Market: Industry Giants and Emerging Leaders:

• IBM Corporation
• Microsoft Corporation
• AstraZeneca
• Sanofi
• GE Healthcare
• Intel Corporation
• NVIDIA Corporation
• Alphabet Inc. (Google)
• BioXcel Therapeutics Inc.
• Enlitic Inc.

Research Methodology

Our research methodology employs a dual approach, combining qualitative insights with rigorous quantitative analysis to provide comprehensive and reliable market intelligence. The process begins with thorough secondary research, drawing from trusted industry publications, proprietary databases, and credible market sources. This is further enhanced by focused primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/ai-in-precision-medicine-market

☛ Segment Covered in the AI in Precision Medicine Market:

By Technology
Deep Learning is at the forefront of the AI in precision medicine market, primarily due to its advanced pattern recognition capabilities and ability to analyze multimodal datasets, including genomics, imaging, and clinical data. Natural Language Processing (NLP) also plays a vital role by enabling the interpretation of unstructured medical information such as clinical notes, medical literature, and patient records. Additionally, Context-Aware Processing is gaining traction as it provides patient-specific insights by factoring in variables such as age and comorbidities. Querying Methods further enhance clinical decision-making by extracting structured insights from complex data sources.

By Component
Software continues to dominate the market, as it is central to data analysis, predictive modeling, and diagnostic assistance within precision medicine workflows. Hardware also plays a critical role, especially with specialized AI workloads that rely on GPUs and other accelerators to support deep learning applications. Meanwhile, services-including consulting, customization, and system integration-are experiencing growing adoption as healthcare providers and research institutions seek tailored solutions for implementation and scaling.

By Application (Therapeutic Area)
Oncology represents the largest application segment, leveraging AI in biomarker discovery, treatment response prediction, and personalized treatment stratification. Neurology is emerging as one of the fastest-growing areas, with AI applied in diagnosing and managing complex neurological conditions. Cardiology and respiratory applications are also expanding steadily as AI enhances early detection, disease monitoring, and treatment optimization.

☛ This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Top-down and bottom-up approach for regional analysis

📌 Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=ai-in-precision-medicine-market

☛ Regional Analysis for AI in Precision Medicine Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.